Radius Health, a biotech focused on osteoporosis, oncology, and endocrine diseases, reported positive results from an early trial of its breast cancer drug, sending the stock soaring 15.3%. The results, presented at the San Antonio Breast Cancer Symposium, were from a phase 1 clinical study of…
News
- What Happened in the Stock Market Today
- SA medical technology company acquires Danish venture
Aabout 10 months after securing regulatory approval to market its SPEAC System medical device, Brain Sentinel Inc. is expanding its assets and its footprint. The San Antonio-based company, which has created a wearable product to monitor seizure activity, has acquired a Danish biotech that is…
- Faces
Lake Superior College announced Patricia Kingsley, Anthony Marcuson and Joel Madson represented LSC during the annual Biomedical Research Conference for Minority ... The following area residents graduated from basic military training at Joint Base San Antonio-Lackland in San Antonio.
- S&P 500 returns to record following strong US jobs report
Biotechnology stocks helped lead the market, and health care stocks in the S&P 500 rose 1.1 percent for one of the biggest gains of the 11 sectors that make up the index. Alexion Pharmaceuticals jumped $7.68, or 7.2 percent, to $114.46 for the biggest gain in the S&P 500 following a…
- Erytech Pharma Plummets on Phase 2 Data -- Biotech Movers
Shares rose 7.3% to $29.40 after the Waltham, Mass.-based firm on Thursday gave an update on data from the Phase 1 study of elacestrant (RAD1901) in patients with estrogen receptor positive (ER+) breast cancer. The data presentation took place at the 2017 San Antonio Breast Cancer Symposium.